PD
Phillip B. Donenberg

Phillip B. Donenberg insider trades: Taysha Gene Therapies (TSHA) stock purchases

Taysha Gene Therapies Last trade Aug 16, 2023 47 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2006
10
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Phillip reports to the SEC

and 4 more companies

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 16, 2023TSHA↑ Buy$100K
Feb 2, 2022TSHA↑ Buy$23K
Feb 17, 2021AVRO↑ Buy$23K
Aug 8, 2011BPAX↑ Buy$2K
Aug 5, 2011BPAX↑ Buy$2K
Jan 21, 2011BPAX↑ Buy$2K
Jan 19, 2011BPAX↑ Buy$2K
Dec 31, 2008BPAX↑ Buy$3K
Dec 14, 2007BPAX↑ Buy$4K
Jul 20, 2006BPA↑ Buy$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TSHA insiders

Open-market trades in the last 12 months

About Phillip B. Donenberg's insider trades

Phillip B. Donenberg is an insider at Taysha Gene Therapies (TSHA). Since Jul 20, 2006, Phillip has reported 10 open-market purchases worth $164K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (34 filings), option exercises (2 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TSHA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.